Letter : Interpreting the Benefit of Dual Antithrombotic Therapy After Iliac Vein Stenting: Signal or Selection Bias?

Abstract

Get full access to this article

View all access options for this article.

References

Qian

Shi

Hao

, et al. One-year outcomes of dual versus single antithrombotic therapy following iliac vein stenting for acute iliofemoral DVT. Angiology. Published online March 26, 2026. doi:10.1177/00033197261430778

Endo

Jahangiri

Horikawa

, et al. Antiplatelet therapy is associated with stent patency after iliocaval venous stenting. Cardiovasc Intervent Radiol. 2018;41(11):1691-1698.

Qiu

Zha

, et al. Systematic review and meta-analysis of iliofemoral stenting for post-thrombotic syndrome. Eur J Vasc Endovasc Surg. 2019;57(3):407-416.

Avgerinos

Black

van Rijn

Jalaie

The role and principles of stenting in acute iliofemoral venous thrombosis. J Vasc Surg Venous Lymphat Disord. 2024;12(5):101868.

Jahangiri

Endo

Al-Hakim

Kaufman

Farsad

Early venous stent failure predicted by platelet count and neutrophil/lymphocyte ratio. Circ J. 2019;83(2):320-326.

Zhang

Wang

Xin

Zhu

Lang

Liquiritin mitigates lower extremity deep vein thrombosis by inhibiting inflammation and oxidative stress via the NF-κB signaling pathway. Thromb J. 2025;23(1):51.